Nabriva Therapeutics plc
NBRVF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $12 | $48 | $41 | $86 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $7 | $13 | $4 | $3 |
| Inventory | $10 | $15 | $6 | $1 |
| Other Curr. Assets | $2 | $5 | $6 | $2 |
| Total Curr. Assets | $31 | $80 | $57 | $91 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $1 | $1 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $32 | $81 | $58 | $94 |
| Liabilities | – | – | – | – |
| Payables | $5 | $4 | $3 | $5 |
| Short-Term Debt | $5 | $4 | $2 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $0 |
| Other Curr. Liab. | $17 | $14 | $13 | $12 |
| Total Curr. Liab. | $28 | $22 | $19 | $17 |
| LT Debt | $0 | $4 | $6 | $35 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $1 | $1 | $2 |
| Total NC Liab. | $1 | $5 | $7 | $36 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $28 | $28 | $25 | $53 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $1 |
| Retained Earnings | -$653 | -$596 | -$546 | -$477 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $656 | $649 | $579 | $518 |
| Total Equity | $3 | $53 | $33 | $41 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $32 | $81 | $58 | $94 |
| Net Debt | -$7 | -$40 | -$34 | -$52 |